COVID-19 Pandemic Pivot Shows the Benefits of Microarray Technology
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Andy Lundin | Jan 6, 2023 | Womens Health |
A new study by investigators embarked on a study to create a targeted test for predicting placenta accreta spectrum (PAS) during pregnancy.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Cardiovascular |
CareDx announced the publication of International Society for Heart and Lung Transplantation guidelines supporting its surveillance portfolio.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Cancer, Diagnostic Technologies |
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 2, 2023 | Company News |
Quest Diagnostics and Northern Light Health are collaborating to broaden access to affordable care for communities in Maine.
Read More